ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Senhwa Biosciences Presents Positive Cholangiocarcinoma Data prnasia
January 18, 2021Senhwa Biosciences, Inc., a clinical-stage biopharmaceutical company focused on next generation DNA Damage Response (DDR) therapeutics for the treatment of cancer, announces that promising clinical data from their global phase 1b/2 trial, evaluating ...
Pharma Sources Insight January 2025
